MBX Biosciences, Inc. (MBX) Insider Ownership

Historic Ownership Trends

According to recent filings covering the 90 days ending December 12, 2025, the three most significant insider holders at MBX Biosciences are Director Patrick J Heron (5.22Mn shares), President & CEO P. Kent Hawryluk (1.11Mn shares), Director Steven L. Hoerter (20.00K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares Report Date
Patrick J Heron 5,219,440 30 Sep, 2025
Life Sciences X, L.P. Frazier 4,552,774 17 Sep, 2024
Scott D Sandell 3,614,486 17 Sep, 2024
Anthony A. Jr. Florence 3,614,486 17 Sep, 2024
Ali Behbahani 3,614,486 17 Sep, 2024
Paul Edward Walker 3,614,486 17 Sep, 2024
Mohamad Makhzoumi 3,614,486 17 Sep, 2024
Carmen Chang 3,614,486 17 Sep, 2024
Edward T Mathers 3,614,486 17 Sep, 2024
Enterprise Associates 17, L.P. New 3,614,486 17 Sep, 2024
Rick Yang 3,614,486 17 Sep, 2024
Forest Baskett 3,614,486 17 Sep, 2024
Tiba Aynechi 2,136,335 17 Sep, 2024
Biomedical Innovation Master Investors (Cayman) Ii L.P. Wellington 1,790,122 17 Sep, 2024
P. Kent Hawryluk President & CEO 1,112,533 28 Oct, 2025
Advisors Llc Orbimed 747,887 19 Feb, 2025
Carl L Gordon 747,887 19 Feb, 2025
James M Cornelius 102,082 17 Sep, 2024
Ora H. Pescovitz 24,329 10 Apr, 2025
Steven L. Hoerter 20,000 20 Oct, 2025

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
24 Oct, 2025 P. Kent Hawryluk Common Stock A 182,859 $3.25 664,256 D M
20 Oct, 2025 P. Kent Hawryluk Common Stock A 20,000 $13.64 481,397 D P
17 Oct, 2025 Steven L. Hoerter Common Stock A 20,000 $13.25 20,000 I P
26 Sep, 2025 Patrick J Heron - - 5,219,440 I
26 Sep, 2025 Patrick J Heron Common Stock A 666,666 $18.00 5,219,440 I P
08 Apr, 2025 Ora H. Pescovitz - - 24,329 D
08 Apr, 2025 Ora H. Pescovitz Common Stock A 7,693 $5.89 24,329 D P
14 Feb, 2025 Carl L Gordon - - 3,176,390 I
14 Feb, 2025 Advisors Llc Orbimed Common Stock A 17,962 $9.90 3,176,390 I P
14 Feb, 2025 Carl L Gordon Common Stock A 17,962 $9.90 3,176,390 I P
14 Feb, 2025 Carl L Gordon - - 3,205,930 I
14 Feb, 2025 Carl L Gordon Common Stock A 29,540 $9.85 3,205,930 I P
14 Feb, 2025 Advisors Llc Orbimed Common Stock A 29,540 $9.85 3,205,930 I P
18 Feb, 2025 Carl L Gordon Common Stock A 49,070 $10.84 3,255,000 I P
18 Feb, 2025 Advisors Llc Orbimed Common Stock A 49,070 $10.84 3,255,000 I P
18 Feb, 2025 Carl L Gordon - - 3,255,000 I
18 Feb, 2025 Carl L Gordon - - 747,887 I
18 Feb, 2025 Carl L Gordon Common Stock A 94,100 $10.84 747,887 I P
18 Feb, 2025 Advisors Llc Orbimed Common Stock A 94,100 $10.84 747,887 I P
04 Feb, 2025 P. Kent Hawryluk - - 448,277 I